<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[XenoPort Inc. | Company News & Executive Profiles - XNPT | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/xenoport+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for XenoPort Inc.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[XenoPort's Most Recent Data Points to Larger Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F162179-xenoport-s-most-recent-data-points-to-larger-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: XenoPort XNPT received a big boost  yesterday from positive data on its lead drug, GSK1838262/XP13512 gabapentin enacarbil, in a neuropathic pain trial, the second attempt by the company and its partner GlaxoSmithKline GSK to prove that this product has much larger potential than currently forecast. ...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 18 Sep 2009 01:31:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">GSK,XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-328784.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator instructions Your first question comes from the line of Eric Schmidt of Cowen and Company.  Eric Schmidt &#8211; Cowen and Company  Good afternoon. Thanks for taking my questions. Ron, has the FDA received the open-label expansion data for 512?  Ron Barrett ...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Aug 2009 19:22:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[Advisory Committee]]></category>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F154138-xenoport-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[XenoPort, Inc. XNPT   Q2 2009 Earnings Call Transcript   August 5, 2009 5:00 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Aug 2009 08:22:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort's Solzira a Potential Blockbuster]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143790-xenoport-s-solzira-a-potential-blockbuster%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By Jason Napodano We consider XenoPort's XNPT Analyst Report XP-13512 -- a gabapentin pro-drug, to be called Solzira in the U.S. -- to be a potential blockbuster opportunity with a full label to include restless leg syndrome (RLS), neuropathic pain (PHN / PDN), and migraine prophylaxis....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 17 Jun 2009 11:55:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort, Inc., Q1 2009 Earnings Call Transcript.]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-295853.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions. Your first question comes from the line of David Amsellem with Piper Jaffray.  July Johnson - Piper Jaffray Hi, this is July Johnson for David Amsellem. Thanks for taking my question. The first is on the 986 based study? What dosage of the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 05 May 2009 17:48:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/u.s.+bancorp+piper+jaffray+inc..html"><![CDATA[U.S. Bancorp Piper Jaffray Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-268507.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question will come from the line of Michael Aberman with Credit Suisse. Michael Aberman - Credit Suisse Thank you for taking the question. Can you give us a little better color what we should be looking at in terms of PK in the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Feb 2009 17:36:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/credit+suisse+group+ag.html"><![CDATA[Credit Suisse Group AG]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-252028.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from the line of Rachel McMinn with Cowen & Company. Rachel McMinn &#8211; Cowen & Company Thanks very much, and thanks, Ron, for talking about the disappointing news first. I think you're probably the first guy I've talked to this year...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 24 Nov 2008 10:25:38 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/japan.html"><![CDATA[Japan]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/astellas.html"><![CDATA[Astellas]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Kroger Co., XenoPort, Inc., GlaxoSmithKline Plc., Ltd., Standard Motor Products, Inc. and Vital Images, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_19/ai_n28571417]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Kroger Co. (NYSE: KR), XenoPort, Inc. (Nasdaq: XNPT), GlaxoSmithKline Plc. (NYSE:...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 19 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/kroger+co..html"><![CDATA[Kroger Co.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/standard+motor+products+inc..html"><![CDATA[Standard Motor Products Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SMP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">KR,NDAQ,SMP,XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort to Present at the Morgan Stanley Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_3/ai_n28050675]]></link>
		<description><![CDATA[SANTA CLARA, Calif. -- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Unplugged Conference. The live presentation will occur at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) on Tuesday, September 9, 2008. A...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">MS,XNPT</category>
	</item>
	<item>
		<title><![CDATA[XenoPort Inc.Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224486.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question is from the line of Michael Lee with RBC Capital Market. Michael Lee - RBC Capital Market Great. Thanks Ron. Couple of quick questions, can you remind us or give us an update on what you found from the exposure response analysis...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 Aug 2008 17:32:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
</channel>
</rss>
